Chitturi Trinadha Rao

Title: Chitturi Trinadha Rao: Innovator in Pharmaceutical Chemistry

Introduction

Chitturi Trinadha Rao is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

One of his latest patents is titled "Amidoheteroaryl aroyl hydrazide ethynes." This invention relates to novel amidoheteroaryl aroyl hydrazide ethynes that serve as tyrosine kinase inhibitors. The patent details the process of preparation and the use of these compounds in pharmaceutical compositions aimed at treating disorders related to tyrosine kinases in humans. Another significant patent involves methods for treating inflammatory conditions using a novel anti-inflammatory compound of the androstane series. This compound, identified as S-[4-(3-fluoro-3-methylbutyryloxy)-but-2-ynyl]6α,9α-difluoro-17α-(furan-2-yl)carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate, showcases his innovative approach to addressing inflammation.

Career Highlights

Chitturi Trinadha Rao is currently associated with Sun Pharma Advanced Research Company Limited, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that can significantly impact patient care.

Collaborations

He collaborates with esteemed colleagues such as Hemant Ashvinbhai Chokshi and Sabbirhusen Yusufbhai Chimanwala, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chitturi Trinadha Rao exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions through patents and collaborative efforts highlight the importance of research in developing effective medical treatments.